← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

KVUE logoKenvue Inc.(KVUE)Earnings, Financials & Key Ratios

KVUE•NYSE
$17.68
$33.87B mkt cap·32.7× P/E·Price updated May 6, 2026
SectorConsumer DefensiveIndustryHousehold ProductsSub-IndustryConsumer Health and Wellness Products
AboutKenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.Show more
  • Revenue$15.46B
  • EBITDA$2.46B-21.5%
  • Net Income$1.03B-38.1%
  • EPS (Diluted)0.54-37.9%
  • Gross Margin57.97%+3.6%
  • EBITDA Margin15.94%-21.6%
  • Operating Margin11.91%-26.8%
  • Net Margin6.66%-38.1%
  • ROE9.87%-7.6%
  • ROIC7.76%-5.1%
  • Debt/Equity0.90+20.0%
  • Interest Coverage4.27-39.1%
Analysis→Technical→

KVUE Key Insights

Kenvue Inc. (KVUE) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Healthy dividend yield of 4.6%

✗Weaknesses

  • ✗Dividend payout exceeds 100% of earnings

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

KVUE Price & Volume

Kenvue Inc. (KVUE) stock price & volume — 10-year historical chart

Loading chart...

KVUE Growth Metrics

Kenvue Inc. (KVUE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years0.88%
TTM-2.93%

Profit CAGR

10 Years-
5 Years-
3 Years-20.86%
TTM34.68%

EPS CAGR

10 Years-
5 Years-
3 Years-21.11%
TTM36.31%

Return on Capital

10 Years7.86%
5 Years7.86%
3 Years10.34%
Last Year8.72%

KVUE Recent Earnings

Kenvue Inc. (KVUE) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 7/12 qtrs (58%)
Q1 2026Latest
Feb 17, 2026
EPS
$0.27
Est $0.22
+21.2%
Revenue
$3.8B
Est $3.7B
+2.6%
Q4 2025
Nov 3, 2025
EPS
$0.28
Est $0.26
+7.6%
Revenue
$3.8B
Est $3.8B
-1.5%
Q3 2025
Aug 7, 2025
EPS
$0.29
Est $0.28
+2.9%
Revenue
$3.8B
Est $3.9B
-0.4%
Q2 2025
May 8, 2025
EPS
$0.24
Est $0.23
+5.5%
Revenue
$3.7B
Est $3.7B
+1.7%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 17, 2026
$0.27vs $0.22+21.2%
$3.8Bvs $3.7B+2.6%
Q4 2025Nov 3, 2025
$0.28vs $0.26+7.6%
$3.8Bvs $3.8B-1.5%
Q3 2025Aug 7, 2025
$0.29vs $0.28+2.9%
$3.8Bvs $3.9B-0.4%
Q2 2025May 8, 2025
$0.24vs $0.23+5.5%
$3.7Bvs $3.7B+1.7%
Based on last 12 quarters of dataView full earnings history →

KVUE Peer Comparison

Kenvue Inc. (KVUE) competitors in Consumer Health and Wellness Products — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
PG logoPGThe Procter & Gamble CompanyDirect Competitor345.67B147.9322.720.29%14.66%23.78%0.68
CL logoCLColgate-Palmolive CompanyDirect Competitor70.73B88.1633.521.4%10.46%251.59%21.88
CHD logoCHDChurch & Dwight Co., Inc.Direct Competitor22.49B94.9631.441.57%11.81%17.45%0.55
EL logoELThe Estée Lauder Companies Inc.Direct Competitor31.29B86.67-27.51-8.46%-1.67%-6.29%2.44
PRGO logoPRGOPerrigo Company plcProduct Competitor1.69B12.26-1.19-2.75%-43.5%-50.65%1.35
HLN logoHLNHaleon plcProduct Competitor41.1B9.2318.87-3.96%14.46%19.9%0.52
COTY logoCOTYCoty Inc.Product Competitor2.33B2.65-6.02-3.68%-9.26%-14.21%1.07
JNJ logoJNJJohnson & JohnsonSupply Chain541.31B224.6238.794.3%27.26%31.69%0.51

Compare KVUE vs Peers

Kenvue Inc. (KVUE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PG

Most directly comparable listed peer for KVUE.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare KVUE against a more recognizable public peer.

Peer Set

Compare Top 5

vs PG, CL, CHD, EL

KVUE Income Statement

Kenvue Inc. (KVUE) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue14.47B15.05B14.95B15.44B15.46B15.01B
Revenue Growth %-4.06%-0.69%3.3%0.07%-2.93%
Cost of Goods Sold6.62B6.63B6.67B6.8B6.5B6.28B
COGS % of Revenue45.75%44.07%44.58%44.04%42.03%-
Gross Profit
7.85B▲ 0%
8.42B▲ 7.3%
8.29B▼ 1.6%
8.64B▲ 4.3%
8.96B▲ 3.7%
8.72B▲ 0%
Gross Margin %54.25%55.93%55.42%55.96%57.97%58.14%
Gross Profit Growth %-7.28%-1.59%4.32%3.66%-
Operating Expenses8.83B5.5B5.61B6.13B7.12B6.36B
OpEx % of Revenue61.01%36.53%37.53%39.7%46.06%-
Selling, General & Admin4.96B5.48B5.63B6.14B6.03B6.08B
SG&A % of Revenue34.26%36.43%37.68%39.76%39%-
Research & Development000000
R&D % of Revenue------
Other Operating Expenses3.87B15M-23M-10M1.09B4M
Operating Income
-979M▲ 0%
2.92B▲ 398.3%
2.67B▼ 8.4%
2.51B▼ 6.1%
1.84B▼ 26.7%
2.36B▲ 0%
Operating Margin %-6.77%19.4%17.89%16.27%11.91%15.74%
Operating Income Growth %-398.26%-8.39%-6.09%-26.71%-
EBITDA-233M3.65B3.32B3.14B2.46B2.93B
EBITDA Margin %-1.61%24.25%22.2%20.32%15.94%19.53%
EBITDA Growth %-1666.95%-9.09%-5.42%-21.54%18.95%
D&A (Non-Cash Add-back)746M731M644M627M622M569M
EBIT2.99B2.92B2.64B2.55B1.85B2.37B
Net Interest Income000-250M-378M-429M
Interest Income000108M53M26M
Interest Expense000358M431M455M
Other Income/Expense-37M5M-38M-322M-426M-444M
Pretax Income
-1.02B▲ 0%
2.92B▲ 387.9%
2.64B▼ 9.8%
2.19B▼ 17.0%
1.42B▼ 35.4%
1.92B▲ 0%
Pretax Margin %-7.02%19.43%17.64%14.18%9.16%12.78%
Income Tax-137M847M573M526M385M485M
Effective Tax Rate %13.48%28.96%21.73%24.02%27.21%25.29%
Net Income
-879M▲ 0%
2.08B▲ 336.4%
2.06B▼ 0.7%
1.66B▼ 19.4%
1.03B▼ 38.1%
1.43B▲ 0%
Net Margin %-6.08%13.8%13.81%10.77%6.66%9.55%
Net Income Growth %-336.41%-0.67%-19.38%-38.1%34.68%
Net Income (Continuing)-879M2.08B2.06B1.66B1.03B1.43B
Discontinued Operations000000
Minority Interest000000
EPS (Diluted)
-0.47▲ 0%
1.10▲ 334.0%
1.08▼ 1.8%
0.87▼ 19.4%
0.54▼ 37.9%
0.75▲ 0%
EPS Growth %-334.04%-1.82%-19.44%-37.93%36.31%
EPS (Basic)-0.471.101.080.900.54-
Diluted Shares Outstanding1.89B1.89B1.91B1.92B1.92B1.92B
Basic Shares Outstanding1.89B1.89B1.91B1.85B1.92B1.92B
Dividend Payout Ratio---874.64%150.68%-

KVUE Balance Sheet

Kenvue Inc. (KVUE) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets4.59B4.93B5.88B6.14B5.53B6.03B
Cash & Short-Term Investments618M740M1.23B1.38B1.07B1.14B
Cash Only618M740M1.23B1.38B1.07B1.14B
Short-Term Investments000000
Accounts Receivable2.13B2.33B2.3B2.64B2.66B2.42B
Days Sales Outstanding53.7456.5256.0862.3962.865.36
Inventory1.69B1.7B2.23B1.85B1.59B1.79B
Days Inventory Outstanding92.9293.63121.999.3489.499.39
Other Current Assets162M154M123M265M205M683M
Total Non-Current Assets24.58B23B21.44B21.71B20.08B21.22B
Property, Plant & Equipment1.96B1.83B1.82B2.04B1.85B2.09B
Fixed Asset Turnover7.39x8.24x8.21x7.56x8.36x7.59x
Goodwill10.33B9.81B9.19B9.27B8.84B9.44B
Intangible Assets11.61B10.7B9.85B9.62B8.47B8.72B
Long-Term Investments000001M
Other Non-Current Assets496M475M434M623M726M2.88B
Total Assets
29.18B▲ 0%
27.93B▼ 4.3%
27.32B▼ 2.2%
27.85B▲ 2.0%
25.6B▼ 8.1%
27.25B▲ 0%
Asset Turnover0.50x0.54x0.55x0.55x0.60x0.56x
Asset Growth %--4.28%-2.19%1.96%-8.08%-8.03%
Total Current Liabilities7.49B4.04B3.93B5.48B5.74B6.16B
Accounts Payable1.58B1.83B1.83B2.49B2.25B2.4B
Days Payables Outstanding87.07100.51100.16133.58126.65138.84
Short-Term Debt000599M1.55B1.95B
Deferred Revenue (Current)000000
Other Current Liabilities252M266M272M406M325M1.42B
Current Ratio0.61x1.22x1.50x1.12x0.96x0.96x
Quick Ratio0.39x0.80x0.93x0.78x0.69x0.69x
Cash Conversion Cycle59.5849.6477.8228.1525.5425.9
Total Non-Current Liabilities3.33B3.49B3.42B11.16B10.19B10.46B
Long-Term Debt008.93B7.69B6.94B7.06B
Capital Lease Obligations082M81M97M189M571.25M
Deferred Tax Liabilities1.76B2.43B2.48B2.62B2.26B9.39B
Other Non-Current Liabilities1.57B976M-8.07B754M802M3.39B
Total Liabilities10.82B7.53B7.35B16.64B15.93B16.61B
Total Debt0129M9.05B8.43B8.72B9.11B
Net Debt-618M-611M7.82B7.04B7.65B7.97B
Debt / Equity-0.01x0.45x0.75x0.90x0.90x
Debt / EBITDA-0.04x2.73x2.68x3.54x3.11x
Net Debt / EBITDA--0.17x2.35x2.24x3.11x3.11x
Interest Coverage---7.02x4.27x5.22x
Total Equity
18.36B▲ 0%
20.4B▲ 11.1%
19.97B▼ 2.1%
11.21B▼ 43.9%
9.67B▼ 13.8%
10.63B▲ 0%
Equity Growth %-11.13%-2.1%-43.86%-13.76%-13.78%
Book Value per Share9.7210.8010.435.855.035.53
Total Shareholders' Equity18.36B20.4B19.97B11.21B9.67B10.63B
Common Stock00019M19M19M
Retained Earnings000429M-93M-136M
Treasury Stock000-7M-242M-439M
Accumulated OCI-3.57B-4.47B-5.46B-5.38B-6.15B-5.13B
Minority Interest000000

KVUE Cash Flow Statement

Kenvue Inc. (KVUE) cash flow — operating, investing & free cash flow history

Line itemDec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations3.4B334M2.52B3.17B1.77B1.77B
Operating CF Margin %23.48%2.22%16.89%20.51%11.45%-
Operating CF Growth %--90.17%655.99%25.47%-44.16%91.81%
Net Income-879M2.03B2.09B1.66B1.03B1.43B
Depreciation & Amortization746M731M644M627M622M567M
Stock-Based Compensation115M141M137M188M254M160M
Deferred Taxes-801M568M157M-114M-285M-51M
Other Non-Cash Items-26M-5M13M6M719M-235M
Working Capital Changes4.24B-3.13B-513M797M-571M262M
Change in Receivables265M-303M-142M44M-218M-22M
Change in Inventory109M-77M-582M349M182M25M
Change in Payables154M330M52M390M-536M-52M
Cash from Investing-83M-171M-390M-488M-425M-493M
Capital Expenditures-229M-295M-375M-469M-434M-503M
CapEx % of Revenue1.58%1.96%2.51%3.04%2.81%-
Acquisitions176M136M-10M21M00
Investments------
Other Investing146M-77M-8M-40M9M10M
Cash from Financing-3.46B0-1.58B-2.53B-1.56B-1.55B
Debt Issued (Net)-11M-7M14M8.25B159M-137M
Equity Issued (Net)0001000K-1000K-2M
Dividends Paid000-14.55B-1.55B-1.58B
Share Repurchases0000-235M-121M
Other Financing-3.45B7M-1.6B-460M63M279M
Net Change in Cash
-134M▲ 0%
122M▲ 191.0%
491M▲ 302.5%
151M▼ 69.2%
-312M▼ 306.6%
82M▲ 0%
Free Cash Flow
3.17B▲ 0%
39M▼ 98.8%
2.15B▲ 5412.8%
2.7B▲ 25.5%
1.33B▼ 50.5%
1.64B▲ 0%
FCF Margin %21.9%0.26%14.38%17.48%8.64%10.92%
FCF Growth %--98.77%5412.82%25.53%-50.54%16.99%
FCF per Share1.680.021.121.410.690.69
FCF Conversion (FCF/Net Income)-3.86x0.16x1.22x1.90x1.72x1.14x
Interest Paid000224M439M0
Taxes Paid448M363M316M699M810M0

KVUE Key Ratios

Kenvue Inc. (KVUE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2021202220232024TTM
Return on Equity (ROE)10.72%10.23%10.67%9.87%13.48%
Return on Invested Capital (ROIC)11.67%8.43%8.18%7.76%7.76%
Gross Margin55.93%55.42%55.96%57.97%58.14%
Net Margin13.8%13.81%10.77%6.66%9.55%
Debt / Equity0.01x0.45x0.75x0.90x0.90x
Interest Coverage--7.02x4.27x5.22x
FCF Conversion0.16x1.22x1.90x1.72x1.14x
Revenue Growth4.06%-0.69%3.3%0.07%-2.93%

KVUE SEC Filings & Documents

Kenvue Inc. (KVUE) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 15, 2026·SEC

Material company update

Feb 17, 2026·SEC

Material company update

Feb 12, 2026·SEC

10-K Annual Reports

1
FY 2026

Feb 20, 2026·SEC

10-Q Quarterly Reports

3
FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 7, 2025·SEC

FY 2025

May 8, 2025·SEC

KVUE Frequently Asked Questions

Kenvue Inc. (KVUE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Kenvue Inc. (KVUE) reported $15.01B in revenue for fiscal year 2024. This represents a 4% increase from $14.47B in 2020.

Kenvue Inc. (KVUE) grew revenue by 0.1% over the past year. Growth has been modest.

Yes, Kenvue Inc. (KVUE) is profitable, generating $1.43B in net income for fiscal year 2024 (6.7% net margin).

Dividend & Returns

Yes, Kenvue Inc. (KVUE) pays a dividend with a yield of 4.56%. This makes it attractive for income-focused investors.

Kenvue Inc. (KVUE) has a return on equity (ROE) of 9.9%. This is below average, suggesting room for improvement.

Kenvue Inc. (KVUE) generated $1.64B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More KVUE

Kenvue Inc. (KVUE) financial analysis — history, returns, DCA and operating performance tools

Full KVUE Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.